ASS1 and non-small cell lung carcinoma: As a targeted metabolic antitumor strategy, the outcome of arginine deprivation is related to the expression of ASS1, which is considered as the key enzyme in arginine biosynthesis and confers ferroptosis resistance in NSCLC [31].